Willy Cowles

Associate
Full contact info

Experience

Eliem Therapeutics – $92 Million IPO

August 10, 2021

Cooley advised Eliem Therapeutics on its $92 million initial public offering of 7,360,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Eliem Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol ELYM, is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Partners Alan Hambelton, Sonya Erickson and Stephen Rosen led the Cooley team.

Related contacts

Alan Hambelton
Partner, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Stephen Rosen
Partner, London
Julia Stark
Associate, Seattle
Willy Cowles
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle

Related Practices & Industries

Resolution Bio Sells to Agilent

April 16, 2021

Cooley advised Resolution Bio on its sale to Agilent, a global leader in the life-sciences, diagnostics, and applied-chemical markets. Partner Laura Medina led the team advising Resolution Bio, a leader in the development and commercialization of next-generation sequencing based precision oncology solutions.

Read more

Related contacts

Laura M. Medina
Partner, Colorado
Megan Browdie
Partner, Washington DC
Willy Cowles
Associate, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Patricia Myers
Paralegal Specialist, Colorado
John Paul Oleksiuk
Partner, New York
Jonathan Rivinus
Partner, Colorado
Megan Drill
Associate, San Diego
Rubin Waranch
Associate, Washington DC
Charity Williams
Partner, San Diego

Related Practices & Industries

Rodeo Therapeutics Agrees to Sell to Amgen for $721 Million

March 31, 2021

Cooley advised Rodeo Therapeutics, a biopharmaceutical company that develops small molecule therapies, on its agreement to sell to Amgen, a leader in biotechnology-based human therapeutics, for $721 million. Partner Laura Medina led the Cooley team advising Rodeo. 

Read more

Related contacts

Meredith Klionsky
Associate, Washington DC
Laura M. Medina
Partner, Colorado
Ajay Athavale
Associate, San Francisco
Willy Cowles
Associate, Seattle
Alexander Ellebracht
Associate, Palo Alto
Charity Williams
Partner, San Diego
Yuri Weigel
Special Counsel, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Jon Cousin
Associate, Washington DC
Patrick Sharma
Associate, Los Angeles Santa Monica
Mark Windfeld-Hansen
Senior Counsel, Palo Alto

Related Practices & Industries